Treatment of dysfunctional uterine bleeding: Patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy

被引:44
|
作者
Bourdrez, P
Bongers, MY
Mol, BWJ
机构
[1] Vie Curi Med Ctr No Limburg, Dept Obstet & Gynaecol, NL-5900 BX Venlo, Netherlands
[2] Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, Netherlands
[3] Univ Utrecht Hosp, Dept Obstet & Gynaecol, Utrecht, Netherlands
关键词
preference; endometrial ablation; levonorgestrel-releasing IUD; hysterectomy;
D O I
10.1016/j.fertnstert.2003.12.025
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To investigate patient preferences for endometrial ablation and a levonorgestrel-releasing intrauterine device (IUD) as alternatives to hysterectomy in the treatment of dysfunctional uterine bleeding. Design: Comparative study based on structured interviews. Setting: A large teaching hospital with 500 beds in the Netherlands. Patient(s): Ninety-six patients who were scheduled for endometrial ablation, 25 patients who were scheduled for hysterectomy, and 23 patients who were scheduled for a levonorgestrel-releasing IUD were interviewed. All of the women had dysfunctional uterine bleeding. Intervention(s): Patients were asked to state their most significant complaints and their reasons for choosing a particular treatment. Subsequently, the preference for endometrial ablation and a levonorgestrel-releasing IUD as alternatives to hysterectomy was assessed during a structured interview. Women were informed about the advantages and disadvantages of all three treatment options. Patients rated their preferences according to different hypothetical success rates. The success rates after endometrial ablation and levonorgestrel-releasing IUD were varied until patients found an acceptable treatment outcome. Main Outcome Measure(s): Patient preference of endometrial ablation and the levonorgestrel-releasing IUD over hysterectomy. Result(s): The main reason for the treatment of choice differed between the three groups. Most of the patients in the hysterectomy group wanted a definite solution to their problems, whereas patients in the levonorgestrel-releasing IUD group and in the ablation group put greater emphasis on a minimally invasive intervention with or without a short hospital stay. In women undergoing ablation, 70% of the patients preferred this treatment and the levonorgestrel-releasing IUD to hysterectomy in cases in which the success rate of noninvasive treatment was presumed to be 50%. In women having a levonorgestrel-releasing IUD inserted, 95% of the patients preferred this approach over hysterectomy in cases in which the success rate of this device was presumed to be 50%, whereas 35% of patients prefer-red ablation over hysterectomy in cases in which the success rate of ablation was presumed to be 50%. In women undergoing hysterectomy, 30% would have opted for ablation and 45% would have opted for a levonorgestrel-releasing IUD in cases in which success rates were 50%. Of patients who opted for hysterectomy, however, 60% stated that they would have preferred a noninvasive treatment if the success rate of this type of treatment were >80%. Conclusion(s): A majority of the patients who had dysfunctional uterine bleeding and who were scheduled for an endometrial ablation or a levonorgestrel-releasing IUD were inclined to take a risk of 50% likelihood of treatment failure to avoid a hysterectomy. As a consequence, research of treatment for dysfunctional uterine bleeding should focus on this 50% success level. (Fertil Steril(R) 2004;82:160-6. (C)2004 by American Society for Reproductive Medicine.)
引用
收藏
页码:160 / 166
页数:7
相关论文
共 50 条
  • [1] Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding
    Crosignani, PG
    Vercellini, P
    Mosconi, P
    Oldani, S
    Cortesi, I
    DeGiorgi, O
    [J]. OBSTETRICS AND GYNECOLOGY, 1997, 90 (02): : 257 - 263
  • [2] Levonorgestrel-releasing intrauterine system vs. transcervical endometrial resection for dysfunctional uterine bleeding
    Gupta, B.
    Mittal, S.
    Misra, R.
    Deka, D.
    Dadhwal, V.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 95 (03) : 261 - 266
  • [3] Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain
    Lete, I.
    Cristobal, I.
    Febrer, L.
    Crespo, C.
    Arbat, A.
    Hernandez, F. J.
    Brosa, M.
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 154 (01) : 71 - 80
  • [4] Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding
    Beelen, Pleun
    van den Brink, Marian J.
    Herman, Malou C.
    Geomini, Peggy M. A. J.
    Dekker, Janny H.
    Duijnhoven, Ruben G.
    Mak, Nienke
    van Meurs, Hannah S.
    Coppus, Sjors F.
    van der Steeg, Jan Willem
    Eising, Heleen P.
    Massop-Helmink, Diana S.
    Klinkert, Ellen R.
    Nieboer, Theodoor E.
    Timmermans, Anne
    van der Voet, Lucet F.
    Veersema, Sebastiaan
    Smeets, Nicol A. C.
    Schutte, Joke M.
    van Baal, Marchien
    Bossuyt, Patrick M.
    Mol, Ben Willem J.
    Berger, Marjolein Y.
    Bongers, Marlies Y.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02)
  • [7] Comparison of the levonorgestrel-releasing intrauterine system, hysterectomy, and endometrial ablation for heavy menstrual bleeding in a decision analysis model'
    Louie, Michelle
    Spencer, Jennifer
    Wheeler, Stephanie
    Ellis, Victoria
    Toubia, Tarek
    Schiff, Lauren D.
    Siedhoff, Matthew T.
    Moulder, Janelle K.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2017, 139 (02) : 121 - 129
  • [8] Use of the levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas
    Silva, JCRE
    Silva, ACJSRE
    Reis, FJC
    Manetta, LA
    Ferriani, RA
    Nogueira, AA
    [J]. RESEARCH PAPERS IN FERTILITY AND REPRODUCTIVE MEDICINE, 2004, 1271 : 388 - 391
  • [9] Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas
    Silva, JCRE
    Silva, ACJDRE
    dos Reis, FJC
    Manetta, LA
    Ferriani, RA
    Nogueira, AA
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 2005, 50 (08) : 613 - 617